Cancer ​drug developer ‌Aktis Oncology ‌said on Thursday it priced ⁠its ‌upsized U. initial ‍public offering at $18 per ​share, raising ‌about $318 million.

Markets are making gains ahead of a landmark day with a potential ruling on the legality of tariffs from the Supreme Court ...

Johnson & ​Johnson ‌said on Thursday ‌it has reached a ⁠agreement ‌with U. President ‍Donald Trump's administration to ​cut ‌drug prices for Americans in exchange ⁠for exemptions ​from ​U.

Elon Musk's artificial intelligence startup xAI reported a net ​loss of $1.46 billion for the ‌September quarter, compared with a loss of $1 billion in ‌the previous three months, Bloomberg News ...

When it comes to claiming that Venezuelan oil is now under his control, President Donald Trump is mincing no words. After all, Trump is expected to visit Beijing in April as part of an effort to ...

Back in the 1980s, rotisserie chicken may have existed, but it was not a staple in the way it has become today. Costco, for ...

The United Nations is forecasting that the global economy will grow by 2.7% this year, slightly lower than last year's ...

Jan 8 () - AnaptysBio said on Thursday it filed a partial motion to dismiss a claim by GSK's oncology ​unit, which alleges ...

Market Domination Overtime host Josh Lipton previews several of the biggest stories to come tomorrow, Friday, January 8, including the release of the December jobs report, a possible Supreme Court ...

A certified financial planner breaks down the seven tiers of retirement and how to manage them, from investing to debt ...

If you are wondering whether Nokia Oyj at €5.57 is offering fair value or a possible bargain, it helps to look past the headline share price and focus on what the underlying numbers suggest. Over the ...

Supreme Court is set to issue rulings on Friday on cases related to the legality of ​tariffs imposed by President Donald ...